Evaluation of Chronic Orthostatic Intolerance
NCT00069693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2017-07-02
Summary
This study will conduct tests with patients with primary chronic orthostatic intolerance (COI) to learn more about this disorder of the autonomic nervous system.
Healthy normal volunteers and patients 18 years of age and older with COI may be eligible for this study. Participants undergo one or more of the following tests and procedures:
* Blood studies, including arterial catheter insertion to measure blood pressure and collect arterial blood samples, blood flow studies using sensors applied to the skin and a pressure cuff around a limb, blood volume studies using injection of radioactively labeled human serum albumin and gene studies to look for genetic abnormalities associated with certain proteins.
* Imaging studies, including CT scan of the adrenal glands, heart ultrasound, and PET scanning.
* Electrocardiogram
* Microdialysis to measures levels of chemicals in the body fluid of certain tissues. A thin tube is inserted into the skin and a solution is passed through it. Chemicals in the body tissues enter the solution in the tube. The solution is collected and the chemical levels are measured.
* Neck suction. Neck suction is applied to test a reflex the brain uses to regulate blood pressure.
* Perometry. Limb volume is measured using an infrared light that moves up the limb.
* Quantitative sudomotor axon reflex test to evaluate an aspect of autonomic nervous system function. A small amount of a brain chemical (acetylcholine) is applied to the skin with a tiny amount of electricity, and the sweat in a nearby patch of skin is measured.
* Skin electrical conduction test using sensors on the skin to measure sweat production.
* Skin and core temperature measurements using sensors on the skin and in the ear canal.
* Tilt table test. The subject lies on a table, secured with straps around the chest and legs. Sensors are placed on the arms and chest to monitor blood pressure, pulse rate, and heart rhythm. A catheter is placed in a vein in each arm to collect blood samples and give drugs. Another catheter is placed in an artery to draw blood and monitor blood pressure. The subject is given an infusion of norepinephrine and epinephrine, and baseline measures and blood samples are taken. The table is tilted upright and more measurements and blood samples are taken at intervals for up to 30 minutes. The table is returned to a horizontal position and additional measurements and samples may be taken.
Drugs may be administered during the tests, including acetylcholine, epinephrine, and norepinephrine, radioactive chemicals used in imaging studies, and drugs that affect blood vessels, heart rate, and force of heart contractions.
Conditions
- Syncope
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-26
- Completion
- 2008-08-05
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence
NCT00190996 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
NCT00190814 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence
NCT00190632 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of VA106483 in Males With Nocturia.
NCT01038843 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
NCT00323635 ·Status: TERMINATED ·Phase: PHASE4
-
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms
NCT00244296 ·Status: COMPLETED ·Phase: PHASE4
-
Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
NCT00190567 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT00290563 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms
NCT04999657 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
NCT01223937 ·Status: COMPLETED ·Phase: PHASE3
-
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
NCT00332319 ·Status: TERMINATED ·Phase: PHASE2
-
Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
NCT04227184 ·Status: COMPLETED ·Phase: PHASE4
-
Urge Incontinence Bladder Overactivity Study
NCT00475696 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
NCT00304499 ·Status: COMPLETED ·Phase: PHASE3
-
DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence
NCT03397771 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Digital Therapeutics (One.Dr) for Suspected Orthostatic Hypotension Patients
NCT07348445 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Duloxetine in the Treatment of Stress Urinary Incontinence.
NCT00191087 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
NCT02240459 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
NCT00752141 ·Status: COMPLETED ·Phase: PHASE1
-
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
NCT02410135 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
NCT00196404 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Stress Urinary Incontinence Study
NCT00475358 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis
NCT01956591 ·Status: COMPLETED